Moderna set to deliver 14m. more doses of COVID-19 vaccine to Canada
Within Canada's previous agreement, it held an option to increase its purchase depending on how Moderna's trial phases panned out.
A handout photo shows an employee demonstrating a vial with "Gam-COVID-Vac" vaccine against the coronavirus disease (COVID-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), during its production at Binnopharm ph(photo credit: REUTERS)ByJERUSALEM POST STAFF